Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure.
Mayui NakazawaTsuyoshi SuzukiTsuyoshi ShigaAtsushi SuzukiNobuhisa HagiwaraPublished in: Journal of arrhythmia (2020)
Our study showed that only one-fourth of Japanese patients with end-stage HF underwent deactivation of ICD therapy. A relatively high frequency of shock therapy was observed in the last month before death.